Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313982) titled 'LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION' on Dec. 18, 2025.
Study Type: Observational
Primary Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition:
Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
Recruitment Status: Recruiting
Date of First Enrollment: December 31, 2025
Target Sample Size: 350
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07313982
Published by HT Digital Content Services with permission from Health Daily Digest....